BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $321,017 | -20.0% | 8,506 | -3.5% | 0.01% | -14.3% |
| Q2 2023 | $401,383 | +10.7% | 8,810 | -1.5% | 0.01% | 0.0% |
| Q1 2023 | $362,606 | -26.5% | 8,940 | -7.6% | 0.01% | -30.0% |
| Q4 2022 | $493,237 | -4.0% | 9,677 | +1.5% | 0.01% | -9.1% |
| Q3 2022 | $514,000 | -17.8% | 9,534 | -2.0% | 0.01% | -15.4% |
| Q2 2022 | $625,000 | -32.3% | 9,731 | -18.3% | 0.01% | -23.5% |
| Q1 2022 | $923,000 | -18.4% | 11,904 | -9.6% | 0.02% | -10.5% |
| Q4 2021 | $1,131,000 | +2.4% | 13,168 | -4.2% | 0.02% | -5.0% |
| Q3 2021 | $1,105,000 | -5.7% | 13,744 | -5.6% | 0.02% | -13.0% |
| Q2 2021 | $1,172,000 | -12.9% | 14,561 | -8.7% | 0.02% | -14.8% |
| Q1 2021 | $1,345,000 | +2.0% | 15,948 | -3.0% | 0.03% | 0.0% |
| Q4 2020 | $1,318,000 | -8.9% | 16,434 | -8.6% | 0.03% | -20.6% |
| Q3 2020 | $1,446,000 | -9.5% | 17,979 | -3.1% | 0.03% | -15.0% |
| Q2 2020 | $1,598,000 | -3.1% | 18,558 | -8.6% | 0.04% | -16.7% |
| Q1 2020 | $1,649,000 | -6.0% | 20,306 | -3.2% | 0.05% | +17.1% |
| Q4 2019 | $1,755,000 | -4.0% | 20,986 | +0.3% | 0.04% | -10.9% |
| Q3 2019 | $1,829,000 | +7.5% | 20,918 | +0.6% | 0.05% | +2.2% |
| Q2 2019 | $1,702,000 | -3.1% | 20,788 | -3.8% | 0.04% | -4.3% |
| Q1 2019 | $1,756,000 | +15.8% | 21,602 | -6.2% | 0.05% | +2.2% |
| Q4 2018 | $1,516,000 | -14.7% | 23,041 | 0.0% | 0.05% | -8.0% |
| Q3 2018 | $1,777,000 | +20.0% | 23,041 | +14.8% | 0.05% | +11.1% |
| Q2 2018 | $1,481,000 | +16.2% | 20,066 | +2.5% | 0.04% | +15.4% |
| Q1 2018 | $1,274,000 | -3.6% | 19,581 | -4.3% | 0.04% | 0.0% |
| Q4 2017 | $1,322,000 | +2.5% | 20,453 | -0.5% | 0.04% | -2.5% |
| Q3 2017 | $1,290,000 | +1.6% | 20,553 | -2.0% | 0.04% | +2.6% |
| Q2 2017 | $1,270,000 | +15.3% | 20,976 | -1.2% | 0.04% | +14.7% |
| Q1 2017 | $1,101,000 | +10.7% | 21,241 | -5.3% | 0.03% | +6.2% |
| Q4 2016 | $995,000 | -43.0% | 22,435 | -38.9% | 0.03% | -46.7% |
| Q3 2016 | $1,746,000 | +21.2% | 36,694 | +15.2% | 0.06% | +17.6% |
| Q2 2016 | $1,440,000 | +17.5% | 31,851 | +6.7% | 0.05% | +18.6% |
| Q1 2016 | $1,226,000 | +38.4% | 29,841 | +28.4% | 0.04% | +13.2% |
| Q4 2015 | $886,000 | +7.4% | 23,241 | -7.5% | 0.04% | +2.7% |
| Q3 2015 | $825,000 | -72.5% | 25,128 | -41.5% | 0.04% | -70.4% |
| Q2 2015 | $3,004,000 | -33.0% | 42,949 | -34.4% | 0.12% | -32.8% |
| Q1 2015 | $4,482,000 | -23.1% | 65,437 | -17.7% | 0.19% | -24.1% |
| Q4 2014 | $5,830,000 | -2.7% | 79,549 | -4.8% | 0.24% | -7.2% |
| Q3 2014 | $5,994,000 | -5.9% | 83,519 | -5.2% | 0.26% | -2.9% |
| Q2 2014 | $6,371,000 | -4.1% | 88,114 | -2.4% | 0.27% | -7.5% |
| Q1 2014 | $6,643,000 | -12.0% | 90,282 | -16.8% | 0.29% | -12.0% |
| Q4 2013 | $7,549,000 | -1.0% | 108,532 | -6.6% | 0.33% | -4.8% |
| Q3 2013 | $7,629,000 | +18.9% | 116,144 | +25.4% | 0.35% | +18.2% |
| Q2 2013 | $6,414,000 | – | 92,595 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |